Sex-related differences in self-reported treatment burden in patients with atrial fibrillation

BackgroundTreatment burden (TB) is defined as the patient’s workload of healthcare and its impact on patient functioning and wellbeing. High TB can lead to non-adherence, a higher risk of adverse outcomes and lower quality of life (QoL). We have previously reported a higher TB in patients with atria...

Full description

Bibliographic Details
Main Authors: Miroslav Mihajlovic, Jelena Simic, Milan Marinkovic, Vladan Kovacevic, Aleksandar Kocijancic, Nebojsa Mujovic, Tatjana S. Potpara
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1029730/full
_version_ 1798044803370319872
author Miroslav Mihajlovic
Miroslav Mihajlovic
Jelena Simic
Milan Marinkovic
Vladan Kovacevic
Aleksandar Kocijancic
Nebojsa Mujovic
Nebojsa Mujovic
Tatjana S. Potpara
Tatjana S. Potpara
author_facet Miroslav Mihajlovic
Miroslav Mihajlovic
Jelena Simic
Milan Marinkovic
Vladan Kovacevic
Aleksandar Kocijancic
Nebojsa Mujovic
Nebojsa Mujovic
Tatjana S. Potpara
Tatjana S. Potpara
author_sort Miroslav Mihajlovic
collection DOAJ
description BackgroundTreatment burden (TB) is defined as the patient’s workload of healthcare and its impact on patient functioning and wellbeing. High TB can lead to non-adherence, a higher risk of adverse outcomes and lower quality of life (QoL). We have previously reported a higher TB in patients with atrial fibrillation (AF) vs. those with other chronic conditions. In this analysis, we explored sex-related differences in self-reported TB in AF patients.Materials and methodsA single-center, prospective study included consecutive patients with AF under drug treatment for at least 6 months before enrollment from April to June 2019. Patients were asked to voluntarily and anonymously answer the Treatment Burden Questionnaire (TBQ). All patients signed the written consent for participation.ResultsOf 331 patients (mean age 65.4 ± 10.3 years, mean total AF history 6.41 ± 6.62 years), 127 (38.4%) were females. The mean TB was significantly higher in females compared to males (53.7 vs. 42.6 out of 170 points, p < 0.001), and females more frequently reported TB ≥ 59 points than males (37.8% vs. 20.6%, p = 0.001). In females, on multivariable analysis of the highest TB quartile (TB ≥ 59), non-vitamin K Antagonist Oral Anticoagulant (NOAC) use [Odds Ratio (OR) 0.319; 95% Confidence Interval (CI) 0.12–0.83, P = 0.019], while in males, catheter ablation and/or ECV of AF (OR 0.383; 95% CI 0.18–0.81, P = 0.012) were negatively associated with the highest TB quartile.ConclusionOur study was the first to explore the sex-specific determinants of TB in AF patients. Females had significantly higher TB compared with males. Approximately 2 in 5 females and 1 in 5 males reported TB ≥ 59 points, previously shown to be an unacceptable burden of treatment for patients. Using a NOAC rather than vitamin K antagonist (VKA) in females and a rhythm control strategy in males could decrease TB to acceptable values.
first_indexed 2024-04-11T23:10:12Z
format Article
id doaj.art-d34d7b90cc61498a9bfc0665fc229437
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-11T23:10:12Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-d34d7b90cc61498a9bfc0665fc2294372022-12-22T03:57:53ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-11-01910.3389/fcvm.2022.10297301029730Sex-related differences in self-reported treatment burden in patients with atrial fibrillationMiroslav Mihajlovic0Miroslav Mihajlovic1Jelena Simic2Milan Marinkovic3Vladan Kovacevic4Aleksandar Kocijancic5Nebojsa Mujovic6Nebojsa Mujovic7Tatjana S. Potpara8Tatjana S. Potpara9School of Medicine, University of Belgrade, Belgrade, SerbiaCardiology Clinic, University Clinical Centre of Serbia, Belgrade, SerbiaSchool of Medicine, University of Belgrade, Belgrade, SerbiaCardiology Clinic, University Clinical Centre of Serbia, Belgrade, SerbiaCardiology Clinic, University Clinical Centre of Serbia, Belgrade, SerbiaCardiology Clinic, University Clinical Centre of Serbia, Belgrade, SerbiaSchool of Medicine, University of Belgrade, Belgrade, SerbiaCardiology Clinic, University Clinical Centre of Serbia, Belgrade, SerbiaSchool of Medicine, University of Belgrade, Belgrade, SerbiaCardiology Clinic, University Clinical Centre of Serbia, Belgrade, SerbiaBackgroundTreatment burden (TB) is defined as the patient’s workload of healthcare and its impact on patient functioning and wellbeing. High TB can lead to non-adherence, a higher risk of adverse outcomes and lower quality of life (QoL). We have previously reported a higher TB in patients with atrial fibrillation (AF) vs. those with other chronic conditions. In this analysis, we explored sex-related differences in self-reported TB in AF patients.Materials and methodsA single-center, prospective study included consecutive patients with AF under drug treatment for at least 6 months before enrollment from April to June 2019. Patients were asked to voluntarily and anonymously answer the Treatment Burden Questionnaire (TBQ). All patients signed the written consent for participation.ResultsOf 331 patients (mean age 65.4 ± 10.3 years, mean total AF history 6.41 ± 6.62 years), 127 (38.4%) were females. The mean TB was significantly higher in females compared to males (53.7 vs. 42.6 out of 170 points, p < 0.001), and females more frequently reported TB ≥ 59 points than males (37.8% vs. 20.6%, p = 0.001). In females, on multivariable analysis of the highest TB quartile (TB ≥ 59), non-vitamin K Antagonist Oral Anticoagulant (NOAC) use [Odds Ratio (OR) 0.319; 95% Confidence Interval (CI) 0.12–0.83, P = 0.019], while in males, catheter ablation and/or ECV of AF (OR 0.383; 95% CI 0.18–0.81, P = 0.012) were negatively associated with the highest TB quartile.ConclusionOur study was the first to explore the sex-specific determinants of TB in AF patients. Females had significantly higher TB compared with males. Approximately 2 in 5 females and 1 in 5 males reported TB ≥ 59 points, previously shown to be an unacceptable burden of treatment for patients. Using a NOAC rather than vitamin K antagonist (VKA) in females and a rhythm control strategy in males could decrease TB to acceptable values.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1029730/fullatrial fibrillationtreatment burdensex-related differencesquality of lifefemale sex
spellingShingle Miroslav Mihajlovic
Miroslav Mihajlovic
Jelena Simic
Milan Marinkovic
Vladan Kovacevic
Aleksandar Kocijancic
Nebojsa Mujovic
Nebojsa Mujovic
Tatjana S. Potpara
Tatjana S. Potpara
Sex-related differences in self-reported treatment burden in patients with atrial fibrillation
Frontiers in Cardiovascular Medicine
atrial fibrillation
treatment burden
sex-related differences
quality of life
female sex
title Sex-related differences in self-reported treatment burden in patients with atrial fibrillation
title_full Sex-related differences in self-reported treatment burden in patients with atrial fibrillation
title_fullStr Sex-related differences in self-reported treatment burden in patients with atrial fibrillation
title_full_unstemmed Sex-related differences in self-reported treatment burden in patients with atrial fibrillation
title_short Sex-related differences in self-reported treatment burden in patients with atrial fibrillation
title_sort sex related differences in self reported treatment burden in patients with atrial fibrillation
topic atrial fibrillation
treatment burden
sex-related differences
quality of life
female sex
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1029730/full
work_keys_str_mv AT miroslavmihajlovic sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT miroslavmihajlovic sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT jelenasimic sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT milanmarinkovic sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT vladankovacevic sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT aleksandarkocijancic sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT nebojsamujovic sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT nebojsamujovic sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT tatjanaspotpara sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation
AT tatjanaspotpara sexrelateddifferencesinselfreportedtreatmentburdeninpatientswithatrialfibrillation